Shigehisa Kitano

6.9k citations

157 papers · 3.4k indexed · h-index 31

Oncology top 1%
- Cancer Immunotherapy and Biomarkers 83
- CAR-T cell therapy research 28
- Colorectal Cancer Treatments and Studies 9
Immunology top 1%
- Immunotherapy and Immune Responses 32
- Immune Cell Function and Interaction 19
- Immune cells in cancer 15
Cancer Research top 10%
Pulmonary and Respiratory Medicine top 5%
- Lung Cancer Treatments and Mutations 9
Molecular Biology top 10%
Radiology, Nuclear Medicine and Imaging
- Monoclonal and Polyclonal Antibodies Research 10

Co-authors: Jedd D. Wolchok Noboru Yamamoto Alexander M. Lesokhin Daniel Hirschhorn-Cymerman Taha Merghoub Jianda Yuan Czrina Cortez Takayuki Nakayama
Cited by: Oncology Immunology Cancer Research
Journals: The Journal of Experimental Medicine (1 paper)Journal of Clinical Oncology (26 papers)SHILAP Revista de lepidopterología (2 papers)
Partner nations: Japan United States United Kingdom

In The Last Decade

Shigehisa Kitano

136 papers receiving 3.4k citations

Peers

Countries citing papers authored by Shigehisa Kitano

Since Specialization

Citations

This map shows the geographic impact of Shigehisa Kitano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shigehisa Kitano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shigehisa Kitano more than expected).

Fields of papers citing papers by Shigehisa Kitano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shigehisa Kitano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shigehisa Kitano. The network helps show where Shigehisa Kitano may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Shigehisa Kitano, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Shigehisa Kitano Line = papers co-authored together Shigehisa Kitano links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Phase Ib trial of tasurgratinib (E7090) with or without endocrine therapies for patients (pts) with ER+, HER2− recurrent/metastatic breast cancer (BC) after receiving a CDK4/6 inhibitor. Journal of Clinical Oncology ·Takahiro Kogawa,Toshinari Yamashita,Takanori Ishida,Kan Yonemori,Hiroji Iwata,Akihiko Shimomura,Kenjiro Aogi,Kenichi Inoue,Toru Mukohara,Takahiro Nakayama,Hitomi Sakai,Shigehisa Kitano,Shingo Kobayashi,Takuya Nakada,Ippei Suzuki,Yohei Otake,Junji Tsurutani	2024	1
2	Effects of the Cortisol Milieu on Tumor-Infiltrating Immune Cells in Corticotroph Tumors Endocrinology ·Maki Kanzawa,Hiroki Shichi,Keitaro Kanie,Masaaki Yamamoto,Naoki Yamamoto,Yasutaka Tsujimoto,Hironori Bando,Genzo Iguchi,Shigehisa Kitano,Naoko Inoshita,Shozo Yamada,Wataru Ogawa,Tomoo Itoh,Hidenori Fukuoka	2024	1
3	Severe drug eruption after antibiotic administration in patients receiving immune checkpoint inhibitors: A monocentric case series SHILAP Revista de lepidopterología ·Aya Nishizawa,Koichi Takeda,Tetsuya Urasaki,Makiko Ono,Toshiaki Mochizuki,Taro Shiga,Motohiro Fujiwara,Takeshi Yuasa,Atsushi Murakami,Ryo Koike,Mayu Yunokawa,Hiroyuki Kanao,Keitaro Shimozaki,Daisuke Takahari,Takahiro Kogawa,Shunji Takahashi,Shigehisa Kitano	2023	0
4	Safety and Efficacy of NY-ESO-1 Antigen-Specific T-Cell Receptor Gene-Transduced T Lymphocytes in Patients with Synovial Sarcoma: A Phase I/II Clinical Trial Clinical Cancer Research ·Akira Kawai,Mikiya Ishihara,Tomoki Nakamura,Shigehisa Kitano,Shintaro Iwata,Kohichi Takada,Makoto Emori,Koji Kato,Makoto Endo,Yoshihiro Matsumoto,Shigeki Kakunaga,Eiichi Sato,Yoshihiro Miyahara,Kunihiko Morino,Shinya Tanaka,Shuichi Takahashi,Fujio Matsuo,Akihiko Matsumine,Shinichi Kageyama,Takafumi Ueda	2023	10
5	A feasibility study of lenvatinib plus pembrolizumab in Japanese patients with advanced solid tumors Cancer Chemotherapy and Pharmacology ·Shigehisa Kitano,Yutaka Fujiwara,Toshio Shimizu,Satoru Iwasa,Kan Yonemori,Shunsuke Kondo,Akihiko Shimomura,Takafumi Koyama,Takahiro Ebata,Hiroki Ikezawa,Nozomi Hayata,Yukinori Minoshima,Takuma Miura,Tomoki Kubota,Noboru Yamamoto	2022	5
6	First‐in‐human study of ONO‐4578, an antagonist of prostaglandin E₂ receptor 4, alone and with nivolumab in solid tumors Cancer Science ·Satoru Iwasa,Takafumi Koyama,Makoto Nishino,Shunsuke Kondo,Kazuki Sudo,Kan Yonemori,Tatsuya Yoshida,Kenji Tamura,Toshio Shimizu,Yutaka Fujiwara,Shigehisa Kitano,Akihiko Shimomura,Jun Sato,Fumiharu Yokoyama,Hiroyuki Iida,Maki Kondo,Noboru Yamamoto	2022	13
7	The real-world safety of atezolizumab as second-line or later treatment in Japanese patients with non-small-cell lung cancer: a post-marketing surveillance study Japanese Journal of Clinical Oncology ·Yuichiro Ohe,Naoya Yamazaki,Nobuyuki Yamamoto,Haruyasu Murakami,Kiyotaka Yoh,Shigehisa Kitano,Hideyuki Hashimoto,Ayako Murayama,Sayuri Nakane,Akihiko Gemma	2022	7
8	Safety and efficacy of nivolumab plus bevacizumab, paclitaxel for HER2-negative metastatic breast cancer: Primary results and biomarker data from a phase 2 trial (WJOG9917B) European Journal of Cancer ·Yukinori Ozaki,Junji Tsurutani,Toru Mukohara,Tsutomu Iwasa,Masato Takahashi,Yuko Tanabe,Hidetaka Kawabata,Norikazu Masuda,Manabu Futamura,Hironobu Minami,Koji Matsumoto,Kenichi Yoshimura,Shigehisa Kitano,Toshimi Takano	2022	24
9	Transient Depletion of CD4+ Cells Induces Remodeling of the TCR Repertoire in Gastrointestinal Cancer Cancer Immunology Research ·Hiroyasu Aoki,Satoshi Ueha,Shigeyuki Shichino,Haru Ogiwara,Kohei Shitara,Manami Shimomura,Toshihiro Suzuki,Tetsuya Nakatsura,Makiko Yamashita,Shigehisa Kitano,Sakiko Kuroda,Masashi Wakabayashi,Makoto Kurachi,Satoru Ito,Toshihiko Doi,Kouji Matsushima	2021	13
10	Feasibility Study of Nivolumab as Neoadjuvant Chemotherapy for Locally Esophageal Carcinoma: FRONTiER (JCOG1804E) Future Oncology ·Shun Yamamoto,Ken Kato,Hiroyuki Daiko,Takashi Kojima,Hiroki Hara,Tetsuya Abe,Yasuhiro Tsubosa,Kengo Nagashima,Kazunori Aoki,Yukihiro Mizoguchi,Shigehisa Kitano,Shinichi Yachida,Satoshi Shiba,Yuko Kitagawa	2020	44
11	CD20⁺ tumor‐infiltrating immune cells and CD204⁺ M2 macrophages are associated with prognosis in thymic carcinoma Cancer Science ·Jun Sato,Shigehisa Kitano,Noriko Motoi,Yoshinori Ino,Noboru Yamamoto,Shun‐ichi Watanabe,Yuichiro Ohe,Nobuyoshi Hiraoka	2020	32
12	CD4+ T-cell Immunity in the Peripheral Blood Correlates with Response to Anti-PD-1 Therapy Cancer Immunology Research ·Hiroshi Kagamu,Shigehisa Kitano,Ou Yamaguchi,Kenichi Yoshimura,Katsuhisa Horimoto,Masashi Kitazawa,Kazuhiko Fukui,Ayako Shiono,Atsuhito Mouri,Fuyumi Nishihara,Yu Miura,Kosuke Hashimoto,Yoshitake Murayama,Kyoichi Kaira,Kunihiko Kobayashi	2019	169
13	First‐in‐human phase I study of E7090, a novel selective fibroblast growth factor receptor inhibitor, in patients with advanced solid tumors Cancer Science ·Takafumi Koyama,Toshio Shimizu,Satoru Iwasa,Yutaka Fujiwara,Shunsuke Kondo,Shigehisa Kitano,Kan Yonemori,Akihiko Shimomura,Sakura Iizumi,Tatsuya Sasaki,Junji Furuse,Noboru Yamamoto	2019	24
14	Pretreatment Immune Status Correlates with Progression-Free Survival in Chemotherapy-Treated Metastatic Colorectal Cancer Patients Cancer Immunology Research ·Kohei Tada,Shigehisa Kitano,Hirokazu Shoji,Takashi Nishimura,Yasuhiro Shimada,Kengo Nagashima,Kazunori Aoki,Nobuyoshi Hiraoka,Yoshitaka Honma,Satoru Iwasa,Natsuko Okita,Atsuo Takashima,Ken Kato,Yasuhide Yamada,Naoyuki Katayama,Narikazu Boku,Yuji Heike,Tetsuya Hamaguchi	2016	54
15	Enhancement of antitumor effect by peptide vaccine therapy in combination with anti-CD4 antibody: Study in a murine model Biochemistry and Biophysics Reports ·Norihiro Fujinami,Toshiaki Yoshikawa,Yu Sawada,Manami Shimomura,Tatsuaki Iwama,Shiori Sugai,Shigehisa Kitano,Yasushi Uemura,Tetsuya Nakatsura	2016	13
16	Computational Algorithm-Driven Evaluation of Monocytic Myeloid-Derived Suppressor Cell Frequency for Prediction of Clinical Outcomes Cancer Immunology Research ·Shigehisa Kitano,Michael A. Postow,Carly G.K. Ziegler,Deborah Kuk,Katherine S. Panageas,Czrina Cortez,Teresa Rasalan,Matthew Adamow,Jianda Yuan,Phillip Wong,Grégoire Altan‐Bonnet,Jedd D. Wolchok,Alexander M. Lesokhin	2014	111
17	Paradoxical Activation of T Cells via Augmented ERK Signaling Mediated by a RAF Inhibitor Cancer Immunology Research ·Margaret K. Callahan,Gregg Masters,Christine A. Pratilas,Charlotte E. Ariyan,Jessica Katz,Shigehisa Kitano,Valerie Russell,Ruth Ann Gordon,Shachi Vyas,Jianda Yuan,Ashok Gupta,Jon M. Wigginton,Neal Rosen,Taha Merghoub,Maria Jure‐Kunkel,Jedd D. Wolchok	2013	91
18	Enhancement of Tumor-Reactive Cytotoxic CD4+ T-cell Responses after Ipilimumab Treatment in Four Advanced Melanoma Patients Cancer Immunology Research ·Shigehisa Kitano,Takemasa Tsuji,Caillian Liu,Daniel Hirschhorn-Cymerman,Chrisann Kyi,Zhenyu Mu,James P. Allison,Sacha Gnjatic,Jianda Yuan,Jedd D. Wolchok	2013	96
19	Induction of tumoricidal function in CD4+ T cells is associated with concomitant memory and terminally differentiated phenotype The Journal of Experimental Medicine ·Daniel Hirschhorn-Cymerman,Sadna Budhu,Shigehisa Kitano,Cailian Liu,Feng Zhao,Hong Zhong,Alexander M. Lesokhin,Francesca Avogadri-Connors,Jianda Yuan,Yanyun Li,Alan N. Houghton,Taha Merghoub,Jedd D. Wolchok	2012	115
20	Monocytic CCR2+ Myeloid-Derived Suppressor Cells Promote Immune Escape by Limiting Activated CD8 T-cell Infiltration into the Tumor Microenvironment Cancer Research ·Alexander M. Lesokhin,Tobias M. Hohl,Shigehisa Kitano,Czrina Cortez,Daniel Hirschhorn-Cymerman,Francesca Avogadri,Gabrielle Rizzuto,John J. Lazarus,Eric G. Pamer,Alan N. Houghton,Taha Merghoub,Jedd D. Wolchok	2011	292

About Shigehisa Kitano

Shigehisa Kitano is a scholar working on Oncology, Immunology and Pulmonary and Respiratory Medicine, having authored 157 papers that have together received 3.4k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (83 papers), Immunotherapy and Immune Responses (32 papers), CAR-T cell therapy research (28 papers), Immune Cell Function and Interaction (19 papers), Immune cells in cancer (15 papers), Monoclonal and Polyclonal Antibodies Research (10 papers), Colorectal Cancer Treatments and Studies (9 papers) and Lung Cancer Treatments and Mutations (9 papers). The work is most often cited by research in Oncology (2.3k citations), Immunology (1.6k citations) and Cancer Research (302 citations). Shigehisa Kitano has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Jedd D. Wolchok, Noboru Yamamoto, Alexander M. Lesokhin, Daniel Hirschhorn-Cymerman, Taha Merghoub, Jianda Yuan, Czrina Cortez, Takayuki Nakayama, Alan N. Houghton and Shunsuke Kondo. Their work appears in journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact